SMAD6 and breast carcinoma: Since ER- breast cancer is generally more aggressive and more difficult to treat, a correlation between Smad6 expression and DMFS specifically in this subset of patients clearly demonstrates the clinical relevance of Smad6 and BMP signalling in metastasis formation in breast cancer patients.